These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2476628)

  • 21. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
    Lydford SJ; McKechnie KC; Dougall IG
    Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific receptors for thromboxane A2 in cultured vascular smooth muscle cells of rat aorta.
    Hanasaki K; Nakano K; Kasai H; Arita H; Ohtani K; Doteuchi M
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1170-5. PubMed ID: 2963633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular calcium and myosin light chain phosphorylation during U46619-activated vascular contraction.
    Jiang MJ; Chan CF; Chang YL
    Life Sci; 1994; 54(25):2005-13. PubMed ID: 7515455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-generated thromboxane A2 enhances norepinephrine release from adrenergic nerves.
    Trachte GJ; Stein E
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1139-45. PubMed ID: 2849661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboxane/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-beta.
    Craven PA; Studer RK; DeRubertis FR
    Hypertension; 1996 Aug; 28(2):169-76. PubMed ID: 8707377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboxane A2 augments adrenergic neurotransmission.
    Stein E; Trachte GJ
    Eicosanoids; 1990; 3(4):205-11. PubMed ID: 1963539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for inhibition of sympathetic neurotransmission by endogenously released acetylcholine in the guinea-pig trachea.
    Pendry YD; Maclagan J
    Br J Pharmacol; 1991 Dec; 104(4):817-22. PubMed ID: 1667287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the presence of inhibitory prejunctional thromboxane receptors on the adrenergic nerve terminals of mammalian heart.
    Amerini S; Mantelli L; Rubino A; Ledda F
    Pharmacol Res; 1990; 22 Suppl 1():11-2. PubMed ID: 2178257
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of group B Streptococcus on the responses to U46619, endothelin-1, and noradrenaline in isolated pulmonary and mesenteric arteries of piglets.
    Villamor E; Pérez Vizcaíno F; Tamargo J; Moro M
    Pediatr Res; 1996 Dec; 40(6):827-33. PubMed ID: 8947958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors.
    Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
    Eur J Pharmacol; 1989 Nov; 171(2-3):179-87. PubMed ID: 2533558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
    Williams SP; Dorn GW; Rapoport RM
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.
    Matsuzaki T; Noguchi K; Nakasone J; Uezu K; Higuchi M; Sakanashi M
    Arzneimittelforschung; 1992 Nov; 42(11):1318-22. PubMed ID: 1492844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-affinity thromboxane receptor mediates proliferation in cultured vascular smooth muscle cells of rats.
    Ko FN
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1274-82. PubMed ID: 9261257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced thromboxane receptor affinity and vasoconstrictor responses in placentae from diabetic pregnancies.
    Wilkes BM; Mento PF; Hollander AM
    Placenta; 1994 Dec; 15(8):845-55. PubMed ID: 7886025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboxane A2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells.
    Ishizuka T; Suzuki K; Kawakami M; Hidaka T; Matsuki Y; Nakamura H
    Eur J Pharmacol; 1996 Oct; 312(3):367-77. PubMed ID: 8894620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
    Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
    Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery.
    He GW; Yang CQ
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.